← FDA Drug Approvals (Drugs@FDA)
EGRIFTA
BLA · Biologics License Application · Sponsor: THERATECHNOLOGIES · Approved 2010-11-10
Drug application
- FDA Application #
BLA022505
- Application type
- Biologics License Application
- Brand name
- EGRIFTA
- Generic name
- TESAMORELIN
- Active ingredients
- TESAMORELIN ACETATE
- Dosage form
- POWDER
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- THERATECHNOLOGIES
- Manufacturer
- Theratechnologies Inc.
- First approval
- 2010-11-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown